On 15 JUNE, 2009, CapitalBio Corporation, a leading Chinese diagnostics and life science company which develops and markets biochip technologies, tools and services, and Accesolab the leader in the supply and distribution of laboratory equipment and reagents for research, medicine and industry in Mexico, announced an agreement for the distribution of CapitalBio products and services in Mexico.

“The partnership with Accesolab marks our first collaboration in the Central American region” remarked CEO and founder of CapitalBio, Jing Cheng. “The range of clients that Accesolab has developed over its 20 years in business, from research labs to clinicians and bio-industry, fit well with our range of products. Our cost effective diagnostic and research oriented microarray instruments and kits cater to the emerging molecular testing markets in the Republic”.

Adrian Wolf, CEO of Accesolab commented – “CapitalBio has gained wide respect with its user-friendly laboratory instrumentation and software. We feel that Mexican scientists and doctors will be very interested in CapitalBio’s fully developed “Total Solution” approach to bringing microarray technology to the laboratory and clinic. The validation of their microarray platform in the 2006 US FDA organized quality study indicates the reliability of their products. Their diagnostic TB arrays, food safety arrays and HLA genotyping technology should be of great interest in Mexico.”

About ACCESOLAB, S.A. de C.V.

Accesolab is the leader in the provision of a comprehensive range of laboratory instrumentation, consumables and products to Mexico’s biotechnology industry, as well its life research and medical community. Accesolab is noted for its long term dedication to its customer base, through proficient after-sales service and equipment maintenance. For more information, visit https://www.accesolab.com/.